Par Drugs and Chemicals Limited (PAR.NS)
INR 215.15
(5.23%)
INR 215.15
(5.23%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 202.48 Million | 133.77 Million | 76.15 Million | 120.85 Million | 76.91 Million | 75.77 Million |
| Net Income | 145.01 Million | 150.79 Million | 127.03 Million | 147.26 Million | 59.91 Million | 32.83 Million |
| Depreciation & Amortization | 34.36 Million | 32.33 Million | 32.81 Million | 28.19 Million | 27.61 Million | 30.37 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 20.03 Million | -4.63 Million | -54.25 Million | -3.38 Million | -8.54 Million | 3.04 Million |
| Other non-cash items | 54.77 Million | -44.71 Million | -29.43 Million | -51.21 Million | -2.07 Million | 9.52 Million |
| Investing Cash Flow | -58.38 Million | -73.38 Million | -30.18 Million | 507.07 Thousand | -14.57 Million | -2.54 Million |
| Investments in PPE | -60.8 Million | -76.33 Million | -32.02 Million | -50.49 Million | -15.58 Million | -3.43 Million |
| Acquisitions | 120 Thousand | 2 Million | - | 49.2 Million | 250 Thousand | - |
| Investment purchases | -19 Thousand | - | - | -49.67 Million | - | - |
| Sales/Maturities of investments | - | - | - | 464.85 Thousand | - | - |
| Other Investing Activities | 2.32 Million | 955 Thousand | 1.83 Million | 50.99 Million | 764.78 Thousand | 887 Thousand |
| Financing Cash Flow | - | -24 Thousand | -95.54 Million | 16.48 Million | 11.14 Million | -73.56 Million |
| Debt repayment | - | - | -76.39 Million | -2.27 Million | -57.31 Million | -73.26 Million |
| Dividends payments | - | - | -15.38 Million | -7.69 Million | -9.27 Million | -1000.00 |
| Common Stock Repurchased | - | - | - | - | -7.54 Million | 13.26 Million |
| Common Stock Issuance | - | - | - | - | 85.27 Million | 59.99 Million |
| Other Financing Activities | - | -24 Thousand | -3.76 Million | 26.45 Million | -1.58 Million | -73.55 Million |
| Accounts receivables | 32.36 Million | 14.98 Million | -60.15 Million | -831 Thousand | -38.48 Million | 2.04 Million |
| Accounts payables | -27.35 Million | -25.7 Million | 39.44 Million | 5.13 Million | 12.72 Million | -3.29 Million |
| Inventory | 12.01 Million | -6.66 Million | -17.16 Million | -799.14 Thousand | 13.77 Million | -2.26 Million |
| Other working capital | 3 Million | 12.74 Million | -16.37 Million | -6.88 Million | 3.44 Million | 6.55 Million |
| Cash at beginning of period | 192.41 Million | 162.06 Million | 211.63 Million | 73.79 Million | 305.88 Thousand | 638 Thousand |
| Cash at end of period | 366.53 Million | 222.43 Million | 162.06 Million | 211.63 Million | 73.79 Million | 306 Thousand |
| Capital Expenditure | -60.8 Million | -76.33 Million | -32.02 Million | -50.49 Million | -15.58 Million | -3.43 Million |
| Effect of forex changes on cash | - | 1.00 | - | -301.00 | - | -1000.00 |
| Net cash flow / Change in cash | 174.12 Million | 60.36 Million | -49.57 Million | 137.84 Million | 73.48 Million | -332 Thousand |
| Free Cash Flow | 141.68 Million | 57.43 Million | 44.12 Million | 70.35 Million | 61.32 Million | 72.34 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 25.33 Million | 37.19 Million | 145.01 Million | 34.22 Million | 48.91 Million | 24.67 Million |
| Depreciation & Amortization | - | - | 34.36 Million | 8.65 Million | 8.47 Million | 8.31 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 20.03 Million | - | 11.01 Million | - |
| Other non-cash items | -25.33 Million | -37.19 Million | 54.77 Million | -34.22 Million | -48.91 Million | -24.67 Million |
| Investing Cash Flow | - | - | -58.38 Million | - | -38.88 Million | - |
| Investments in PPE | - | - | -60.8 Million | - | -39.49 Million | - |
| Acquisitions | - | - | 120 Thousand | - | - | - |
| Investment purchases | - | - | -19 Thousand | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 2.32 Million | - | 612 Thousand | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | 32.36 Million | - | -1.03 Million | - |
| Accounts payables | - | - | -27.35 Million | - | - | - |
| Inventory | - | - | 12.01 Million | - | 12.05 Million | - |
| Other working capital | - | - | 3 Million | - | - | - |
| Cash at beginning of period | - | - | 192.41 Million | 298.54 Million | 222.43 Million | 192.41 Million |
| Cash at end of period | - | - | 366.53 Million | 315.84 Million | 298.54 Million | 209.03 Million |
| Capital Expenditure | - | - | -60.8 Million | - | -39.49 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 174.12 Million | 17.3 Million | 76.11 Million | 16.62 Million |
| Free Cash Flow | - | - | 141.68 Million | 17.3 Million | 75.49 Million | 16.62 Million |
1522
REVB
KOCMT
6743
1950
CERGF